Efficacy of Dipotassium Glycyrrhizinate Emollients in the Maintenance Treatment of Adult Atopic Dermatitis
- Conditions
- Adult Atopic Dermatitis
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria:<br><br> - Meet the Williams diagnostic criteria<br><br> - SCORAD scores < 50 points, classified according to the severity levels of SCORAD<br> scores, where scores of 0-25 are categorized as mild, and scores of 26-50 are<br> categorized as moderate<br><br> - No gender limit, age between 18-65 years old.<br><br>Exclusion Criteria:<br><br> - Acute disease with erosion, exudation, secondary infection<br><br> - There are currently other active inflammatory skin diseases<br><br> - Antihistamine was used within 2 weeks prior to enrollment<br><br> - Patients treated with emollients and receiving topical drugs (such as<br> glucocorticoids and calcineurin inhibitors) within 1 week before enrollment<br><br> - Patients have used phototherapy, systemic corticosteroids, immunosuppressants (such<br> as cyclosporine, azathioprine, or immunoglobulin, etc.) within 4 weeks before<br> enrollment<br><br> - The systematic withdrawal time of biological agents or JAK inhibitor (dupilumab,<br> omalizumab, et al) was less than 12 weeks<br><br> - Malignant tumors, chronic systemic diseases (such as diabetes mellitus,<br> hypothyroidism), or other acute and chronic infections<br><br> - Those known to be allergic to the ingredients of emollient or Hydrocortisone cream<br><br> - Patients who have attended or are attending other clinical investigators within<br> three months<br><br> - Patients judged unsuitable by the investigator to participate in this study.
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SCORAD;POEM;NRS;ADCT;DLQI
- Secondary Outcome Measures
Name Time Method